On September 27-29, members of the SoundMind team joined MAPS and the Pittsburgh Psychedelic Society for the Sleeping Octopus Assembly on Psychedelics (SOAP), an annual conference exploring the role of psychedelics in science, medicine, policy, and culture. The event, hosted at a historic mansion in Pittsburgh, PA, featured presentations, panels, and “tentacle” breakout sessions with experts and advocates working to advance psychedelic science, including SoundMind’s own Dr. Hannah McLane, and Dr. Michelle Joy!
Read MoreWe would like to share some of the things we learned at the Psychedelic Medicine and Cultural Trauma workshop in Kentucky, which our entire six-person therapy team attended on August 10–11th. It was an incredible learning and collaborative experience! The workshop was jam-packed with thought-provoking presentations and heartfelt sharing of personal narratives …
Read MoreMDMA, the active ingredient in ecstasy, is now being used to treat post-traumatic stress disorder (PTSD). Several Phase 2 trials have been completed with a total of 107 participants; there was an overall PTSD remission rate of 61% after 2 months and 68% after 12 months.
Read More